Theta Burst Stimulation for Teenage Depression
(SAINT-KID Trial)
Trial Summary
What is the purpose of this trial?
This is a single-site open-label clinical trial of the Stanford Accelerated Intermittent Neuromodulation Therapy (SAINT®) protocol. The goal of this clinical trial is to learn if a new form of transcranial magnetic stimulation (TMS)-known generally as accelerated intermittent theta burst stimulation (aiTBS) and specifically as SAINT®-is effective as a first-line therapy in treating adolescents aged 14-19 years-old in their first episode of depression who have not undergone a full course of depression treatment prior to starting the trial and who remain antidepressant-free throughout the trial. The main questions this trial aims to answer are: * Does SAINT® relieve symptoms of depression as a first-line therapy in adolescents? * Is SAINT® a feasible option as a first-line treatment for adolescent depression? Researchers will measure the depression symptoms in adolescent participants before and after SAINT®. Parents of the adolescent participant will also participate in the study providing information about their experience and preference for TMS as a first-line treatment. Adolescent participants will: * Remain antidepressant-free throughout the study period of 6-7 weeks. * Receive an MRI of their head for precision targeting * Receive 5 days of aiTBS (SAINT®)
Will I have to stop taking my current medications?
Yes, participants must remain antidepressant-free throughout the study, which means stopping any current antidepressant medications.
What data supports the effectiveness of the treatment Accelerated Intermittent Theta Burst Stimulation (SAINT®) for teenage depression?
Research shows that theta burst stimulation (TBS), a type of brain stimulation, has been effective in treating major depression in adults, with significant improvements in depression scores and higher response rates compared to a placebo. This suggests that similar treatments like SAINT® could potentially help with teenage depression as well.12345
Is theta burst stimulation safe for teenagers?
How is the treatment Accelerated Intermittent Theta Burst Stimulation (SAINT®) unique for teenage depression?
Accelerated Intermittent Theta Burst Stimulation (SAINT®) is unique because it is a noninvasive brain stimulation technique that delivers multiple sessions of magnetic pulses to the brain in a short period, potentially offering faster and more efficient relief from depression symptoms compared to traditional treatments.15101112
Research Team
Sean J O'Sullivan, M.D., Ph. D.
Principal Investigator
University of Texas at Austin
Eligibility Criteria
This trial is for teens aged 14-19 with their first major depressive episode, who haven't had a full depression treatment before and can stay off antidepressants. They must be in good health, agree to lifestyle rules during the study, and have ongoing psychiatric care.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 5 days of aiTBS (SAINT®) with either 5 or 10 daily sessions
Follow-up
Participants are monitored for changes in depressive symptoms at baseline and two follow-up visits
Treatment Details
Interventions
- Accelerated Intermittent Theta Burst Stimulation (SAINT®) (Neuromodulation Therapy)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor
Magnus Medical
Industry Sponsor